-
Ozempic Faces $2 Billion in Lawsuits as Patients Report Stomach Paralysis and Vision Loss
August 26, 2025Ozempic, along with sister drugs Wegovy and Rybelsus, belongs to the GLP-1 receptor agonist class of...
-
Johnson & Johnson Launches The 3rd Opinion to Empower Lung Cancer Patients Across Asia Pacific
August 1, 2025Marking World Lung Cancer Day, Johnson & Johnson has unveiled The 3rd Opinion, a groundbreaking initiative...
-
Zydus Receives Tentative USFDA Approval for Ibrutinib Tablets in Multiple Strengths, Targeting $2.1 Billion Market
July 24, 2025Zydus Lifesciences Ltd., one of India’s leading pharmaceutical companies, announced today that it has received tentative...
-
Hypertension Rising Among Women and Youth: Cardiologists Sound Alarm on Silent Threat
May 16, 2025Once considered a condition of ageing, hypertension is increasingly affecting younger populations and women, warn senior...
-
Samarpan Becomes India’s First and Only CARF-Accredited Residential Rehabilitation Center
May 15, 2025India’s mental health and addiction treatment sector, Samarpan, the country’s premier residential rehabilitation centre, has been...
-
4baseCare Launches Genomics Lab in Bengaluru, Unveils Global Cancer Diversity Atlas to Bridge Genomic Data Gap
May 15, 2025In a step toward reshaping cancer care in India and beyond, Bengaluru-based precision oncology company 4baseCare...
-
Zydus MedTech and Braile Biomedica Forge Global Alliance to Launch TAVI Technology in India, Europe, and Beyond
April 18, 2025India-based Zydus MedTech Private Limited and Brazil’s Braile Biomedica have entered into an exclusive licensing agreement...
